Open AccessGenetic variation spectrum in ATP 7B gene identified in Latvian patients with Wilson disease
Author(s) -
Zarina Agnese,
Tolmane Ieva,
Kreile Madara,
Chernushenko Aleksandrs,
Cernevska Gunta,
Pukite Ieva,
Micule Ieva,
Krumina Zita,
Krumina Astrida,
Rozentale Baiba,
Piekuse Linda
Publication year - 2017
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.297
Subject(s) - allele , genotype , genetics , disease , wilson's disease , gene , biology , compound heterozygosity , exon , mutation , latvian , medicine , linguistics , philosophy
Background Wilson disease ( WD ) is an autosomal recessive disorder of copper metabolism caused by allelic variants in ATP 7B gene. More than 500 distinct variants have been reported, the most common WD causing allelic variant in the patients from Central, Eastern, and Northern Europe is H1069Q. Methods All Latvian patients with clinically confirmed WD were screened for the most common mutation p.H1069Q by PCR Bi‐ PASA method. Direct DNA sequencing of gene ATP 7B (all 21 exons) was performed for the patients with WD symptoms, being either heterozygous for H1069Q or without it on any allele. Results We identified 15 different allelic variants along with eight non‐disease‐causing allelic variants. Based on the gene molecular analysis and patients' clinical data variant p.His1069Gln was found in 66.9% of WD alleles. Wide clinical variability was observed among individuals with the same ATP 7B genotype. The results of our study confirm that neurological manifestations of WD are typically present later than the liver disease but no significant association between the presence/absence of the most common genetic variant and mode of initial WD presentation or age at presentation was identified. Conclusions (1) The most prevalent mutation in Latvian patients with Wilson disease was c.3207C>A (p.His1069Gln); (2) No significant phenotype–genotype correlation was found in Latvian patients with Wilson disease; (3) The estimated prevalence of Wilson disease in Latvia is 1 of 24,000 cases which is higher than frequently quoted prevalence of 1: 30,000.